Mutagenic Approaches to Modifying Gap Junction Phenotype

E-ISSN： 1873-5592|3|6|441-453

ISSN： 1389-4501

Source： Current Drug Targets, Vol.3, Iss.6, 2002-12, pp. : 441-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease Modifying Approaches for Alzheimer's Pathology

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1943-1954

Bentham Science Publishers

Access to resources Recommend Favorite

Sarcopenia and some simple approaches to modifying the consequence of ageing

By Lamb Sarah (Sallie)

Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. : 170-172

Royal College Of Physicians

Access to resources Recommend Favorite

Alzheimer's Disease: From Pathogenesis to Disease-Modifying Approaches

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Increase in gap junction conductance by an antiarrhythmic peptide

By Muller A. Gottwald M. Tudyka T. Linke W. Klaus W. Dhein S.

European Journal of Pharmacology, Vol. 327, Iss. 1, 1997-05 ,pp. : 65-72

Elsevier

Access to resources Recommend Favorite

Gap Junction Synthesis and Degradation as Therapeutic Targets

Current Drug Targets, Vol. 3, Iss. 6, 2002-12 ,pp. : 409-416

Bentham Science Publishers

Access to resources Recommend Favorite